La cadena de opciones muestra datos clave de las opciones de acciones de 10x Genomics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para 10x Genomics..

10x Genomics (NASDAQ:TXG) Bolsa, Cadena de Opciones

10X GENOMICS INC-CLASS A

10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Equities

News

ETFs

ACHR

ARKK

PLTR

QCOM

RBLX

Ark Invest vendió acciones de Palantir por 10,4M$. ¿Qué impulsó esta decisión y qué significa para los inversionistas?

Ark Invest ajusta su portafolio: venta masiva de Palantir y nuevas compras estratégicas

10x Genomics Inc

TEXAS GULF ENERGY INC by Texas Gulf Energy, Incorporated.

Texas Gulf Energy Inc

Wells Fargo analyst Matthew Akers maintains Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) with a Overweight and lowers the price target from $148 to $132.

Price Target

Analyst Ratings

SAIC

Wells Fargo Maintains Overweight on Science Applications Intl, Lowers Price Target to $132

Wells Fargo analyst Matthew Akers maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Overweight and lowers the price target from $191 to $173.

LDOS

Wells Fargo Maintains Overweight on Leidos Holdings, Lowers Price Target to $173

Wells Fargo analyst Matthew Akers maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Overweight and lowers the price target from $480 to $438.

CACI

Wells Fargo Maintains Overweight on CACI International, Lowers Price Target to $438

Wells Fargo analyst Matthew Akers maintains Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) with a Overweight and lowers the price target from $164 to $148.

Wells Fargo Maintains Overweight on Booz Allen Hamilton, Lowers Price Target to $148

Wells Fargo analyst Matthew Akers maintains Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) with a Equal-Weight and lowers the price target from $205 to $172.

Wells Fargo Maintains Equal-Weight on Woodward, Lowers Price Target to $172

Wells Fargo analyst Matthew Akers maintains TransDigm Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) with a Overweight and lowers the price target from $1580 to $1410.

Wells Fargo Maintains Overweight on TransDigm Gr, Lowers Price Target to $1410

Wells Fargo analyst Matthew Akers maintains Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) with a Equal-Weight and lowers the price target from $21 to $18.

RKLB

Wells Fargo Maintains Equal-Weight on Rocket Lab USA, Lowers Price Target to $18

Wells Fargo analyst Matthew Akers maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Overweight and lowers the price target from $156 to $136.

Wells Fargo Maintains Overweight on RTX, Lowers Price Target to $136

Wells Fargo analyst Matthew Akers maintains OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) with a Overweight and lowers the price target from $220 to $210.

OSIS

Wells Fargo Maintains Overweight on OSI Systems, Lowers Price Target to $210

Wells Fargo analyst Matthew Akers maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Equal-Weight and lowers the price target from $476 to $432.

Wells Fargo Maintains Equal-Weight on Lockheed Martin, Lowers Price Target to $432

Wells Fargo analyst Matthew Akers maintains L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) with a Overweight and lowers the price target from $268 to $242.

Wells Fargo Maintains Overweight on L3Harris Technologies, Lowers Price Target to $242

16 analysts have shared their evaluations of Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">9</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Autodesk, presenting an average target of $342.81, a high estimate of $400.00, and a low estimate of $285.00. Marking an increase of 1.46%, the current average surpasses the previous average price target of $337.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1744149655_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Autodesk by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ken Wong &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $300.00&#x7C;$350.00 &#x7C; 
&#x7C; Allan Verkhovski &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Outperform&#x7C; $315.00&#x7C;$360.00 &#x7C; 
&#x7C;Saket Kalia &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $365.00&#x7C;$355.00 &#x7C; 
&#x7C;Taylor McGinnis &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $370.00&#x7C;$350.00 &#x7C; 
&#x7C;Adam Borg &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $350.00&#x7C;$360.00 &#x7C; 
&#x7C;William Jellison &#x7C;DA Davidson &#x7C;Raises &#x7C;Neutral &#x7C; $285.00&#x7C;$275.00 &#x7C; 
&#x7C;Jason Celino &#x7C;Keybanc &#x7C;Raises &#x7C;Overweight &#x7C; $335.00&#x7C;$330.00 &#x7C; 
&#x7C;Steve Koenig &#x7C;Macquarie &#x7C;Maintains &#x7C;Outperform &#x7C; $360.00&#x7C;$360.00 &#x7C; 
&#x7C;Joe Vruwink &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $336.00&#x7C;$345.00 &#x7C; 
&#x7C;Keith Weiss &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $385.00&#x7C;$375.00 &#x7C; 
&#x7C;Blair Abernethy &#x7C;Rosenblatt &#x7C;Raises &#x7C;Buy &#x7C; $340.00&#x7C;$325.00 &#x7C; 
&#x7C;Tyler Radke &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $339.00&#x7C;$361.00 &#x7C; 
&#x7C;Blair Abernethy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $325.00&#x7C;$325.00 &#x7C; 
&#x7C;Joe Vruwink &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $345.00&#x7C;$330.00 &#x7C; 
&#x7C;Michael Funk &#x7C;B of A Securities &#x7C;Raises &#x7C;Neutral &#x7C; $335.00&#x7C;$325.00 &#x7C; 
&#x7C;Siti Panigrahi &#x7C;Mizuho &#x7C;Raises &#x7C;Outperform &#x7C; $400.00&#x7C;$280.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Autodesk. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Autodesk compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Autodesk's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Autodesk's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ADSK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Autodesk analyst ratings.</a>
<h2>Discovering Autodesk: A Closer Look</h2>
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction; product design and manufacturing; and media and entertainment. Autodesk software enables design, modeling, and rendering needs of these industries. The company has over 4 million paid subscribers across 180 countries.
<h3>Autodesk: Delving into Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Autodesk's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.57% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Autodesk's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.49% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 11.57%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.89%, the company showcases effective utilization of assets.
Debt Management: Autodesk's debt-to-equity ratio surpasses industry norms, standing at 0.98. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSK

Beyond The Numbers: 16 Analysts Discuss Autodesk Stock

FS KKR Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for FS KKR Capital, presenting an average target of $20.8, a high estimate of $22.00, and a low estimate of $19.00. Highlighting a 0.95% decrease, the current average has fallen from the previous average price target of $21.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744149648_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of FS KKR Capital's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Paul Johnson &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $19.00&#x7C;$22.00 &#x7C; 
&#x7C;Finian O'Shea &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Underweight &#x7C; $19.00&#x7C;$21.00 &#x7C; 
&#x7C;Paul Johnson &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $22.00&#x7C;$21.00 &#x7C; 
&#x7C;Kenneth Lee &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $22.00&#x7C;$21.00 &#x7C; 
&#x7C;Richard Shane &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $22.00&#x7C;$20.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FS KKR Capital. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FS KKR Capital compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of FS KKR Capital's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FS KKR Capital's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FSK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FS KKR Capital analyst ratings.</a>
<h2>Unveiling the Story Behind FS KKR Capital</h2>
FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.
<h3>FS KKR Capital: Financial Performance Dissected</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, FS KKR Capital showcased positive performance, achieving a revenue growth rate of 42.64% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 79.89%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FS KKR Capital's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.21%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): FS KKR Capital's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.0%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: FS KKR Capital's debt-to-equity ratio is below the industry average at 1.11, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 5 Analysts Discuss FS KKR Capital Stock

Throughout the last three months, 9 analysts have evaluated Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $218.0, a high estimate of $257.00, and a low estimate of $170.00. Surpassing the previous average price target of $211.44, the current average has increased by 3.1%.
<img src="https://www.benzinga.com/files/images/story/2025/1744149639_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Capital One Finl's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Richard Shane &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $170.00&#x7C;$198.00 &#x7C; 
&#x7C;Keith Horowitz &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $230.00&#x7C;$245.00 &#x7C; 
&#x7C;Brian Foran &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $215.00&#x7C;$257.00 &#x7C; 
&#x7C;David George &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $200.00&#x7C;$190.00 &#x7C; 
&#x7C;Mihir Bhatia &#x7C;B of A Securities &#x7C;Raises &#x7C;Buy &#x7C; $235.00&#x7C;$207.00 &#x7C; 
&#x7C;Brian Foran &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $257.00&#x7C;$229.00 &#x7C; 
&#x7C;Karl Shepard &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $200.00&#x7C;$190.00 &#x7C; 
&#x7C;Jason Goldberg &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $220.00&#x7C;$219.00 &#x7C; 
&#x7C;Eric Wasserstrom &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $235.00&#x7C;$168.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Capital One Finl. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Capital One Finl compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Capital One Finl's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Capital One Finl's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Capital One Finl analyst ratings.</a>
<h2>Unveiling the Story Behind Capital One Finl</h2>
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
<h3>Financial Insights: Capital One Finl</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3M period, Capital One Finl showcased positive performance, achieving a revenue growth rate of 7.2% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Capital One Finl's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.03%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Capital One Finl's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.65%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.21%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.74, Capital One Finl adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Capital One Finl: Insights From 9 Analyst Reviews

Analysts' ratings for Morgan Stanley Direct (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSDL#NYSE">MSDL</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $20.75, with a high estimate of $22.00 and a low estimate of $20.00. A decline of 1.19% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1744149633_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Morgan Stanley Direct is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ryan Lynch &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $20.00&#x7C;$21.00 &#x7C; 
&#x7C;Kenneth Lee &#x7C;RBC Capital &#x7C;Maintains &#x7C;Outperform &#x7C; $22.00&#x7C;$22.00 &#x7C; 
&#x7C;Finian O'Shea &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $20.00&#x7C;$21.00 &#x7C; 
&#x7C;Finian O'Shea &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $21.00&#x7C;$20.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Morgan Stanley Direct. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Morgan Stanley Direct compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Morgan Stanley Direct's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Morgan Stanley Direct's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MSDL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Morgan Stanley Direct analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Morgan Stanley Direct</h2>
Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.
<h3>Morgan Stanley Direct's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Morgan Stanley Direct's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -7.17%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Morgan Stanley Direct's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 84.26% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Morgan Stanley Direct's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.79%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Morgan Stanley Direct's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Morgan Stanley Direct's debt-to-equity ratio surpasses industry norms, standing at 1.07. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSDL

Breaking Down Morgan Stanley Direct: 4 Analysts Share Their Views

JELD-WEN Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for JELD-WEN Holding, revealing an average target of $6.94, a high estimate of $9.00, and a low estimate of $5.00. Observing a downward trend, the current average is 21.85% lower than the prior average price target of $8.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1744149623_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of JELD-WEN Holding by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Matthew Bouley &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $5.00&#x7C;$6.00 &#x7C; 
&#x7C;Matthew Bouley &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $6.00&#x7C;$9.00 &#x7C; 
&#x7C;Jeffrey Stevenson &#x7C;Loop Capital &#x7C;Lowers &#x7C;Hold &#x7C; $8.00&#x7C;$10.00 &#x7C; 
&#x7C;Keith Hughes &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $7.00&#x7C;$11.00 &#x7C; 
&#x7C;Mike Dahl &#x7C;RBC Capital &#x7C;Lowers &#x7C;Underperform &#x7C; $5.00&#x7C;$7.00 &#x7C; 
&#x7C;Susan Maklari &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Neutral &#x7C; $8.00&#x7C;$9.00 &#x7C; 
&#x7C;John Lovallo &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $7.50&#x7C;$9.00 &#x7C; 
&#x7C;Susan Maklari &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Neutral &#x7C; $9.00&#x7C;$10.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to JELD-WEN Holding. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of JELD-WEN Holding compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of JELD-WEN Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into JELD-WEN Holding's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/JELD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on JELD-WEN Holding analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind JELD-WEN Holding</h2>
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
<h3>JELD-WEN Holding's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: JELD-WEN Holding's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -12.27%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: JELD-WEN Holding's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -7.64% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -10.21%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): JELD-WEN Holding's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -2.51%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.13, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JELD

Deep Dive Into JELD-WEN Holding Stock: Analyst Perspectives (8 Ratings)

In the current session, Energizer Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) is trading at $26.10, after a 3.73% decrease. Over the past month, the stock fell by 14.66%, and in the past year, by 6.67%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1744149616_0.png" alt="Past Year Chart" />

<h3>Evaluating Energizer Hldgs P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Energizer Hldgs has a better P/E ratio of 34.32 than the aggregate P/E ratio of 25.1 of the Household Products industry. Ideally, one might believe that Energizer Hldgs Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744149616_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Energizer Hldgs

Across the recent three months, 10 analysts have shared their insights on Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $270.0, with a high estimate of $310.00 and a low estimate of $213.00. This current average reflects an increase of 4.21% from the previous average price target of $259.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1744149616_0_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Travelers Companies by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Raises &#x7C;Underweight &#x7C; $271.00&#x7C;$260.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $286.00&#x7C;$275.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $275.00&#x7C;$268.00 &#x7C; 
&#x7C;Paul Newsome &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $310.00&#x7C;$259.00 &#x7C; 
&#x7C;Michael Zaremski &#x7C;BMO Capital &#x7C;Raises &#x7C;Outperform &#x7C; $297.00&#x7C;$275.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $287.00&#x7C;$278.00 &#x7C; 
&#x7C;Scott Heleniak &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $268.00&#x7C;$273.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Underweight &#x7C; $225.00&#x7C;$213.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Underweight &#x7C; $213.00&#x7C;$217.00 &#x7C; 
&#x7C;Meyer Shields &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $268.00&#x7C;$273.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Travelers Companies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Travelers Companies compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Travelers Companies's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Travelers Companies's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TRV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Travelers Companies analyst ratings.</a>
<h2>Get to Know Travelers Companies Better</h2>
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance.
<h3>Travelers Companies's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3M period, Travelers Companies showcased positive performance, achieving a revenue growth rate of 9.85% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Travelers Companies's net margin excels beyond industry benchmarks, reaching 17.2%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Travelers Companies's ROE stands out, surpassing industry averages. With an impressive ROE of 7.44%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Travelers Companies's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.54%, the company showcases efficient use of assets and strong financial health.
Debt Management: Travelers Companies's debt-to-equity ratio stands notably higher than the industry average, reaching 0.29. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Travelers Companies Through The Eyes Of 10 Analysts

Wells Fargo analyst Matthew Akers maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Overweight and lowers the price target from $146 to $132.

Wells Fargo Maintains Overweight on Howmet Aerospace, Lowers Price Target to $132

Wells Fargo analyst Matthew Akers maintains Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) with a Overweight and lowers the price target from $87 to $63.

Wells Fargo Maintains Overweight on Hexcel, Lowers Price Target to $63

Press Releases

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Earnings

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

BRKR

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

10x Genomics

10x Genomics (TXG) Opciones

10x Genomics (NASDAQ:TXG) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL